February 18, 2021
1 min read
Save
EMPA-TROPISM
Issue: February 2021
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Left ventricular structure and function parameters in patients with HF with reduced ejection fraction but no diabetes assigned empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) or placebo.